A carregar...
Identifying priority outcomes that influence selection of disease-modifying therapies in MS
BACKGROUND: Persons with multiple sclerosis (MS) may now choose from a broad array of approved disease-modifying treatments (DMTs). The priority that patients and practitioners assign to specific clinical outcomes is likely to influence the MS DMT selection process. METHODS: We invited 9,126 partici...
Na minha lista:
| Publicado no: | Neurol Clin Pract |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6075970/ https://ncbi.nlm.nih.gov/pubmed/30105155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/CPJ.0000000000000449 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|